Labeling efficiency and biodistribution of Technetium-99m labeled nanoparticles: interference by colloidal tin oxide particles

被引:88
作者
Banerjee, T
Singh, AK
Sharma, RK
Maitra, AN [1 ]
机构
[1] Univ Delhi, Dept Chem, Delhi 110007, India
[2] Inst Nucl Med & Allied Sci, Div Biocybernet & Radiopharmaceut, Delhi 110054, India
关键词
(99m) Tc; chitosan nanoparticles; gamma scintigraphy; hydrogels;
D O I
10.1016/j.ijpharm.2004.09.022
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The interference of colloidal tin oxides on the biodistribution of (99m)Technetium radiolabeled chitosan nanoparticles has been overcome by using sodium borohydride instead of commonly used stannous salts as reducing agent for the reduction of Tc-99m (VII) to lower valency states. Biodistribution of radiolabeled chitosan nanoparticles prepared by using stannous chloride method revealed localization of the radioactivity mainly in the liver and spleen while that of radiolabeled chitosan nanoparticles prepared by using sodium borohydride method manifested the presence of radioactivity in blood up to an extent of 10% even after 2 h. Interestingly, the reduction of radioactivity in the latter case with the progress of time was not manifested through an increase in activity in the liver. Rather, a time dependent increased accumulation of radioactive materials was observed in the stomach. From the results it has been concluded that the biodistribution is strongly influenced by the presence of colloidal particles of tin oxides and Tc-99m labeled chitosan nanoparticles are RES evading and long circulating in blood when Tc (VII) is reduced by sodium borohydride and not by stannous chloride during radiolabeling process. (C) 2004 Published by Elsevier B.V.
引用
收藏
页码:189 / 195
页数:7
相关论文
共 11 条
[1]   Preparation, characterization and biodistribution of ultrafine chitosan nanoparticles [J].
Banerjee, T ;
Mitra, S ;
Singh, AK ;
Sharma, RK ;
Maitra, A .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 243 (1-2) :93-105
[2]   Mucoadhesive polymers as platforms for peroral peptide delivery and absorption: synthesis and evaluation of different chitosan-EDTA conjugates [J].
Bernkop-Schnurch, A ;
Krajicek, ME .
JOURNAL OF CONTROLLED RELEASE, 1998, 50 (1-3) :215-223
[3]   PEGylated polycyanoacrylate nanoparticles as vector for drug delivery in prion diseases [J].
Calvo, P ;
Gouritin, B ;
Brigger, I ;
Lasmezas, C ;
Deslys, JP ;
Williams, A ;
Andreux, JP ;
Dormont, D ;
Couvreur, P .
JOURNAL OF NEUROSCIENCE METHODS, 2001, 111 (02) :151-155
[4]   BIODISTRIBUTION OF POLY(BUTYL 2-CYANOACRYLATE) NANOPARTICLES IN RABBITS [J].
DOUGLAS, SJ ;
DAVIS, SS ;
ILLUM, L .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1986, 34 (1-2) :145-152
[5]   Biodistribution of fluoresceinated dextran using novel nanoparticles evading reticuloendothelial system [J].
Gaur, U ;
Sahoo, SK ;
De, TK ;
Ghosh, PC ;
Maitra, A ;
Ghosh, PK .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 202 (1-2) :1-10
[6]  
KOWALSKY RJ, 1987, CHEM PHARM RADIOPHAR, V83
[7]  
Moghimi SM, 2001, PHARMACOL REV, V53, P283
[8]  
Nowotnik D.P., 1990, THEORY PRACTICE GORD, P58
[9]   Stealth® PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting [J].
Peracchia, MT ;
Fattal, E ;
Desmaële, D ;
Besnard, M ;
Noël, JP ;
Gomis, JM ;
Appel, M ;
d'Angelo, J ;
Couvreur, P .
JOURNAL OF CONTROLLED RELEASE, 1999, 60 (01) :121-128
[10]   LONG CIRCULATING MICROPARTICULATE DRUG CARRIERS [J].
STOLNIK, S ;
ILLUM, L ;
DAVIS, SS .
ADVANCED DRUG DELIVERY REVIEWS, 1995, 16 (2-3) :195-214